What is the market valuation of animal vaccines?

The market valuation of the animal vaccines is USD 17.45 billion in 2027.

What is the forecasted size of the animal vaccines industry?

Animal Vaccines Market size was assessed at USD 16.1 billion in 2026 and is poised to grow at a 9.98% CAGR between 2027 and 2036, crossing USD 41.68 billion by 2036.

How are livestock disease outbreaks influencing vaccine procurement strategies in the animal vaccines market?

Disease outbreaks are encouraging producers, veterinary organizations, and public authorities to adopt structured vaccination programs, routine immunization schedules, and emergency stockpiling practices that strengthen long-term vaccine demand.

Why are next-generation vaccine technologies gaining traction in animal health programs?

mRNA and recombinant platforms enable faster vaccine development and adaptation to emerging pathogens, improving response capabilities while supporting product innovation, targeted disease prevention, and investment in advanced veterinary vaccine portfolios.

Why do attenuated live vaccines hold the largest share of the animal vaccines market?

Attenuated live vaccines captured 39.22% of the market in 2026 due to their established role in routine immunization programs, proven field performance, and continued demand across large-scale disease prevention efforts.

Why are companion animals the fastest-growing segment in the animal vaccines market?

The companion animal segment is expanding as pet owners increasingly prioritize preventive healthcare and routine vaccination, supporting stronger adoption of veterinary wellness services.

Why does North America hold the largest share of the animal vaccines market?

North America accounted for 30.24% of the market in 2026, supported by large livestock populations, strong companion animal care spending, and established veterinary healthcare infrastructure.

What is fueling rapid growth in the Asia Pacific animal vaccines market?

Asia Pacific is projected to grow at a 10.85% CAGR due to rising livestock production, increasing vaccination adoption, and a growing focus on preventive animal health management.

Which companies dominate the animal vaccines landscape?

Top companies in the animal vaccines market include Zoetis Inc. (United States), Merck & Co., Inc. (United States), Boehringer Ingelheim Animal Health GmbH (Germany), Elanco Animal Health Incorporated (United States), Virbac S.A. (France), Ceva Santé Animale (France), Phibro Animal Health Corporation (United States), Neogen Corporation (United States), Bimeda Holdings PLC (Ireland), HIPRA, S.A. (Spain).